Provided by Tiger Trade Technology Pte. Ltd.

AEON Biopharma

0.2959
-0.0183-5.82%
Pre-market: 0.2799-0.0160-5.41%09:14 EDT
Volume:507.91K
Turnover:151.37K
Market Cap:14.76M
PE:-0.08
High:0.3100
Open:0.3084
Low:0.2859
Close:0.3142
52wk High:1.45
52wk Low:0.1772
Shares:49.88M
Float Shares:30.51M
Volume Ratio:0.05
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5840
EPS(LYR):-3.9532
ROE:--
ROA:-141.53%
PB:-0.96
PE(LYR):-0.07

Loading ...

AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference

GlobeNewswire
·
Yesterday

AEON Stores Renews Connected IT Services Pact With AEON Group Unit ADMC

TIPRANKS
·
Aug 28

NYSE American Most Active Issues

Dow Jones
·
Aug 28

AEON Stores Widens Interim Loss as Costs Weigh on Flat Revenue

TIPRANKS
·
Aug 27

NYSE American Most Active Issues

Dow Jones
·
Aug 27

AEON Biopharma Names Former FDA Neuroscience Leader Paul Lee Acting Chief Regulatory Officer

Reuters
·
Aug 24

AEON Stores Calls September EGM to Approve Renewal Offer

TIPRANKS
·
Aug 24

AEON Stores Reschedules Extraordinary General Meetings and Adjusts Book Closure Dates

TIPRANKS
·
Aug 24

Major Investor Quietly Makes Bold Move Into AEON Biopharma Stock

TIPRANKS
·
Aug 22

AEON Biopharma 10% Owner Timothy P. Lynch Buys 1,150,000 Shares for $243,455

Reuters
·
Aug 22

AEON Biopharma’s Timothy P. Lynch Files Initial Beneficial Ownership Statement

Reuters
·
Aug 22

AEON CREDIT Restores Public Float Above Regulatory Threshold Following Share Sale

Stock News
·
Aug 20

AEON Stores Delays Dispatch of Circular on Connected Transactions

TIPRANKS
·
Aug 19

AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®

GlobeNewswire
·
Aug 19

AEON Credit Moves to Restore Public Float After Stake Buildup by FMR LLC

TIPRANKS
·
Aug 19

FMR LLC Boosts Stake in AEON Credit with 66,000-Share Purchase at HK$9.17 Each

Deep News
·
Aug 19

AEON Fantasy Posts Strong July Sales in Japan as Overseas Recovery Remains Mixed

TIPRANKS
·
Aug 17

Aeon Biopharma price target lowered to $1.20 from $5 at H.C. Wainwright

TIPRANKS
·
Aug 16

AEON Biopharma Price Target Cut to $1.20/Share from $5.00 by HC Wainwright & Co.

Dow Jones
·
Aug 15

Jasper Therapeutics Q2 Loss Per Share Beats Estimates, Raises $132 Mln

Reuters
·
Aug 14